A. Urani et al., The antidepressant-like effect induced by sigma 1-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test, J PHARM EXP, 298(3), 2001, pp. 1269-1279
Citations number
55
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
The interaction of neuroactive steroids with the sigma (1)-receptor was inv
estigated in Swiss mice submitted to the forced swimming test. The sigma (1
)-agonists igmesine and (+)-SKF-10,047 and the steroid dehydroepiandrostero
ne sulfate (DHEAS) showed some antidepressant-like activity by shortening t
he immobility time, these effects being blocked by the sigma (1)-antagonist
BD1047 or progesterone. The sigma (1)-agonist PRE-084 or pregnenolone sulf
ate failed to affect the immobility time. In adrenalectomized/ castrated (A
dX/CX) mice, the effects of igmesine and DHEAS were significantly potentiat
ed, and PRE-084 or pregnenolone sulfate induced significant decreases of im
mobility time. The augmented effects in AdX/CX were fully blocked by BD1047
. The effects of the classical antidepressants, desipramine or fluoxetine,
were unchanged in AdX/CX mice. The effect of stress on the sigma (1)-recept
or binding and neurosteroid levels was then examined in different brain str
uctures, in terms of in vivo (+)-[H-3]SKF-10,047 binding to sigma (1)-sites
and neurosteroids levels. In the hippocampus, but not in the cortex or cer
ebellum, inhibition of in vivo (+)-[H-3]SKF-10,047 binding was measured in
parallel to the extent of progesterone levels according to the endocrine co
nditions. These data confirmed the antidepressant ability of sigma (1)-rece
ptor agonists and revealed that the endogenous steroidal levels tonically i
nterfere with the efficacy of the sigma (1)-system. It was observed that lo
cal modifications in progesterone levels are directly related to the change
s of in vivo sigma (1)-binding. Such observations may be of major importanc
e in view of the therapeutic use of selective sigma (1)-agonists in depress
ion.